KR890006251A - 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법 - Google Patents

고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법 Download PDF

Info

Publication number
KR890006251A
KR890006251A KR1019880012721A KR880012721A KR890006251A KR 890006251 A KR890006251 A KR 890006251A KR 1019880012721 A KR1019880012721 A KR 1019880012721A KR 880012721 A KR880012721 A KR 880012721A KR 890006251 A KR890006251 A KR 890006251A
Authority
KR
South Korea
Prior art keywords
transferrin
purity
virus
biologically active
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019880012721A
Other languages
English (en)
Korean (ko)
Inventor
베트케 울프
코테 노르베르트
루드니크 디터
묄러 볼프강
클로프트 미카엘
Original Assignee
한스 쉴로이스너
바이오테스트 파르마 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한스 쉴로이스너, 바이오테스트 파르마 게엠베하 filed Critical 한스 쉴로이스너
Publication of KR890006251A publication Critical patent/KR890006251A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet [UV] radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019880012721A 1987-10-01 1988-09-30 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법 Withdrawn KR890006251A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3733181A DE3733181C1 (de) 1987-10-01 1987-10-01 Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates
DEP3733181.7 1987-10-01

Publications (1)

Publication Number Publication Date
KR890006251A true KR890006251A (ko) 1989-06-12

Family

ID=6337381

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012721A Withdrawn KR890006251A (ko) 1987-10-01 1988-09-30 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법

Country Status (8)

Country Link
US (1) US5041537A (enExample)
EP (1) EP0309787B1 (enExample)
JP (1) JPH01106828A (enExample)
KR (1) KR890006251A (enExample)
AT (1) ATE77242T1 (enExample)
DE (2) DE3733181C1 (enExample)
ES (1) ES2042667T3 (enExample)
GR (1) GR3005037T3 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
DE4039721A1 (de) * 1990-12-13 1992-06-17 Behringwerke Ag Verfahren zur herstellung eines pasteurisierten und eisenfreien human-transferrins und seine verwendung
US5986067A (en) * 1991-02-08 1999-11-16 The University Of Vermont And State Agricultural College Recombinant transferrins, transferrin half-molecules and mutants thereof
CA2103583C (en) * 1991-02-08 2009-10-13 Walter D. Funk Recombinant transferrins, transferrin half-molecules and mutants thereof
US6825037B1 (en) 1991-02-08 2004-11-30 University Of Vermont Recombinant transferrins, transferrin half-molecules and mutants thereof
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US6326473B1 (en) 1998-12-30 2001-12-04 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
US6251860B1 (en) * 1998-07-07 2001-06-26 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
GB0711424D0 (en) * 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
JP2012516878A (ja) 2009-02-06 2012-07-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 精製プロセス
CA2797059A1 (en) * 2010-05-03 2011-11-10 Glaxosmithkline Biologicals S.A. Novel method
ES2598627T5 (es) 2011-11-11 2020-02-03 Fundacio Inst Dinvestigacio En Ciencies De La Salut Germans Trias I Pujol Apotransferrina para el tratamiento del ictus cerebral
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2022271955A1 (en) 2021-06-23 2022-12-29 Musc Foundation For Research Development Novel targeted shrna nanoparticles for cancer therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1048150B (it) * 1973-10-31 1980-11-20 O T I Officina Terapeutica Ita Metodo per l isolamento delle transferine da materiali biologici
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPS6054287B2 (ja) * 1983-10-19 1985-11-29 株式会社ミドリ十字 血漿蛋白の加熱処理方法
US4841026A (en) * 1987-01-27 1989-06-20 Miles Laboratories, Inc. Virally inactivated, non-toxic, human transferrin preparation

Also Published As

Publication number Publication date
DE3733181C1 (de) 1989-01-19
GR3005037T3 (enExample) 1993-05-24
US5041537A (en) 1991-08-20
ES2042667T3 (es) 1993-12-16
JPH01106828A (ja) 1989-04-24
EP0309787B1 (de) 1992-06-17
EP0309787A2 (de) 1989-04-05
DE3872137D1 (de) 1992-07-23
ATE77242T1 (de) 1992-07-15
EP0309787A3 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
KR890006251A (ko) 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법
DE68909724T2 (de) Gereinigte hämoglobin-lösungen und verfahren zur herstellung.
EP0374625B1 (en) Viral inactivation process
AU737986B2 (en) Purification of von willebrand factor by cation exchange chromatography
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
JPH0231689A (ja) 百日咳トキシンの精製法
KR890000165B1 (ko) 혈장분획을 열처리하는 방법
GB2061285A (en) Purification of interferon
GB2134528A (en) Method of isolation of colony-stimulating factor and kallikrein originating from human urine
SE505274C2 (sv) Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
DE69106407T2 (de) Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.
Heckly et al. Toxins of Pseudomonas pseudomallei II: Characterization
EP4610276A1 (en) Method for preparing high-purity and high-stability protein
CA1337688C (en) Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
EP1928915B1 (en) An ultra-high yield intravenous immune globulin preparation
DE69736115T2 (de) Verfahren zur herstellung von gereinigtem transferrin
LT3422B (en) Method of preparing lysozyme dimers
JPS5758629A (en) Separating and purifying method of colonization stimulating factor and callicrein in human urine
JPS6160050B2 (enExample)
CN113801221B (zh) 一种抗海蛇毒血清纳米膜过滤方法
EP0369167B1 (en) Method for removing a pyrogen
EP0368808A2 (en) Immobilized enzyme and a method for application thereof
Matsumura et al. Large scale production and characterization of lyophilized pyridoxalated hemoglobin-polyoxyethylene (PHP)
Polet The effect of lymphokines on the growth, the metabolism, and the functions of the cellular membrane of Chang liver cells in vitro
Roth The preparation, partial purification, and application of a cellulase from Myrothecium verrucaria

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880930

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid